News Releases

Date	Title and Summary	View
Jul 19, 2021	Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2021
Jul 14, 2021	Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene NEW BRUNSWICK, N.J. , July 14, 2021 /PRNewswire/ -- Johnson & Johnson Consumer Inc. (JJCI) (NYSE: JNJ) is voluntarily recalling all lots of five NEUTROGENA ® and AVEENO ® aerosol sunscreen product lines to the consumer level. Internal testing identified low levels of benzene in some samples of the
Jul 12, 2021	Janssen Announces U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Jul 09, 2021	STELARA® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
Jul 01, 2021	Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response
Jun 23, 2021	JOHNSON & JOHNSON VISION BRINGS TECNIS SYNERGY AND TECNIS SYNERGY TORIC II PC-IOLS TO NORTH AMERICA FOR CATARACT PATIENTS
Jun 23, 2021	Janssen Submits New Drug Application to U.S. FDA for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
Jun 22, 2021	DARZALEX®▼ (daratumumab) Subcutaneous (SC) Formulation Becomes the First Approved Treatment for Newly Diagnosed Systemic Light Chain Amyloidosis in Europe and Gains an Additional Approval in Pre-Treated Multiple Myeloma
Jun 21, 2021	ETHICON EXPANDS ADVANCED BIOPOLAR ENERGY PORTFOLIO WITH LAUNCH OF ENSEAL X1 CURVED JAW TISSUE SEALER
Jun 12, 2021	Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible